September 30, 2025
Corista, a digital pathology company, expands its executive team, welcoming new members who bring decades of experience in commercial and product development.
Concord, Mass — September 30, 2025 — Corista, a leader in digital pathology and image management, is proud to announce key executive appointments. Wayne Butler, an experienced professional in digital pathology, has been promoted to Chief Commercial Officer and Executive Vice President. Additionally, Conner Wingard has been appointed Chief Technology Officer and Executive Vice President.
Mr. Butler's career at Corista began after a distinguished tenure in digital pathology, where he sold hardware and software solutions to leading healthcare and biopharma organizations. Having served as Head of Sales and Vice President, he now assumes a new role overseeing Sales, Business Development, Customer Strategy, Marketing, and Quality. In this expanded capacity, he will drive sustainable revenue growth, foster continued international market expansion, and manage ongoing regulatory affairs.
Bringing nearly 13 years of experience at Corista, Mr. Wingard has been promoted to the executive team, where he will oversee Engineering, Product Development, Support, and Operations. He will focus on expanding product capabilities and strengthening Corista's market position by incorporating customer and market feedback. Mr. Wingard has been key in enhancing DP3's functionalities to serve clinical, research, and academic clients.
Corista is expanding to meet the demands of a rapidly growing market, and this leadership transition highlights the company's momentum and commitment to long-term growth. Co-Chairs and Founders, Elizabeth and Richard Wingard, stated, “We are delighted to welcome Wayne and Conner to the Senior Executive team and extend our sincere gratitude for their dedication to quality, growth, and customer success. We believe their day-to-day leadership will significantly impact both our Company and the market during this growth phase.”
This strategic step signifies a new chapter in Corista’s evolution and conveys a strong signal to the market of forthcoming advancements.
About Corista
Established in 2005, Corista provides the pathology industry with the most comprehensive suite of digital pathology image management tools for workflow efficiency, data management, integrated analytics, and collaborative tools. Its DP3® digital pathology image management system empowers physicians and researchers globally by enabling computational pathology and interoperable solutions that aim to foster physician collaboration.
DP3 is CE-marked for IVD use in Europe and licensed by Health Canada for clinical diagnoses. For more information, visit www.corista.com.